AT THE FOREFRONT OF
CRISPR THERAPEUTICS DEVELOPMENT
A NOVEL CRISPR TECHNOLOGY
Directly addressing the inherent limitations of current CRISPR methodologies, we seek to unlock previously unattainable avenues in the development of CRISPR based therapeutics.
TECHNOLOGICAL FEATURES
Unprecedented
Corrective
Repair Rates
Safety from
off-target
and
Immunogenicity
Unique
RNP Delivery
Highly Efficient
Cellular Delivery
"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
PROF. GEORGE CHURCH, CRISPR PIONEER
FIND OUT MORE.
CONTACT US.
AddressIn
Institut NEOMED
7171 Frederick Banting
Saint-Laurent H4S 1Z9
(Québec) Canada